# Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Page: https://stenobird.com/podcast/lung-cancer-update-827388/immunotherapy-and-nontargeted-approaches-for-nsclc-fourth-annual-national-general-medical-oncology-summit
Text version: https://stenobird.com/podcast/lung-cancer-update-827388/immunotherapy-and-nontargeted-approaches-for-nsclc-fourth-annual-national-general-medical-oncology-summit.md
Podcast: [Lung Cancer Update](https://stenobird.com/podcast/lung-cancer-update-827388)
Published: 2025-05-18T13:00:00+00:00
Episode link: https://lung-cancer-update.captivate.fm/episode/5353-gmo25-nontargetednsclc
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/9f83b985-830b-453f-bb08-196f139c7e81.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/immunotherapy-and-nontargeted-approaches-for-nsclc-fourth-annual-national-general-medical-oncology-summit
Duration seconds: 3015

## Resource

Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches.   CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/immunotherapy-and-nontargeted-approaches-for-nsclc-fourth-annual-national-general-medical-oncology-summit/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/lung-cancer-update-827388/immunotherapy-and-nontargeted-approaches-for-nsclc-fourth-annual-national-general-medical-oncology-summit.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.